Living Systematic Reviews (LSRs) are comprehensive literature reviews that are continually updated, incorporating relevant new evidence as it becomes available when published in databases and clinical trial registries, which is used to conduct meta-analyses for various safety, immunogenicity and efficacy endpoints.
A robust methodological framework, including PRISMA guidelines for reporting, ensures high-quality evidence synthesis. Including a diverse range of populations, such as children, pregnant persons, and adults, allows for a comprehensive evaluation of vaccine safety and efficacy among key at-risk groups.
Chikungunya Vaccines for Pregnant Persons and Children
In collaboration with Instituto de Efectividad Clínica y Sanitaria (IECS) and Tulane University, SPEAC’s Special Populations team has launched a Living Systematic Review focused on the safety, effectiveness, and immunogenicity of Chikungunya (CHKV) vaccines.
- Protocols: Pregnant Persons & Children
- Manuscripts
Lassa Fever Vaccines for Pregnant Persons and Children
In collaboration with Instituto de Efectividad Clínica y Sanitaria (IECS) and Tulane University, SPEAC’s Special Populations team has launched a Living Systematic Review focused on the safety, effectiveness, and immunogenicity of Lassa Fever vaccines.
Mpox Vaccines for Pregnant Persons and Children
Coming Soon